Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

beverley-carr-enhanced

Beverley Carr appointed Chief Business Officer for Amphista Therapeutics

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing amphista, appointments

Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (TPD) …
Appointment

Mogrify appoint Tom Graney Non-Executive Director, Audit Chair and Capital Markets Advisor

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, mogrify

Mogrify Limited have announced the appointment of Tom Graney, CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He …
Appointment

Plan C COVID strategy being discussed by government

October 27, 2021 Research and Development

An advisor to the Department of Health told MPs a ‘Plan C’ has been mentioned in Government discussions, should the …
News

Quell Therapeutics receives CTA approval to begin first clinical trial with a multi-modular engineered treg cell company

October 27, 2021 Research and Development

The MHRA has approved Quell Therapeutics’ first clinical trial for its lead cell therapy candidate QEL-001. This approval paves the …
News

Study finds link between COVID-19 infection and neurological complications

October 27, 2021 Research and Development

A study conducted by Nature Medicine has revealed an increased risk of Guillain-Barre Syndrome (GBS) and Bell’s palsy following a …
News

FDA and EMA approve Novartis’ treatment for follicular lymphoma patients

October 27, 2021 Research and Development

The FDA and EMA have accepted Novartis’ Supplemental Biologics License Application (sBLA) and Type II Variation for KymriahⓇ in patients …
News

IXICO partner with Microsoft to enhance AI platform

October 20, 2021 Research and Development

IXICO, an AI data analytics company delivering insights into neuroscience, have announced a collaboration with Microsoft to develop its AI …
News

Synairgen COVID-19 treatment moves to Phase III trials

October 20, 2021 Research and Development

Synairgen PLC have said that its anti-viral treatment for severe lung infections is advancing to the final stage of clinical …
News

Pharma Innovation Award given to Stevanato Group for AI-ready vision Robot Unit

October 20, 2021 Research and Development

Stevanato Group, a global provider of processes and services for the Pharmaceutical and Healthcare industry, has been announced as a …
News
mufid-majnun-oi20ehignd4-unsplash

UK COVID deaths highest since March – Doctors call for urgent return of restrictions

October 20, 2021 Research and Development

Medical professionals in the NHS have urgently pleaded the UK government to reimpose COVID restrictions as UK COVID deaths reach …
News

England care staff shortage puts thousands at risk

October 20, 2021 Research and Development

Managers of community care services for over 15,000 people in England say that staff shortages have led to them turning …
News

Verona Pharma to present Phase II data with pMDI for COPD patients

October 13, 2021 Research and Development

Clinical-stage biopharmaceutical company, Verona Pharma plc (Verona), is due to present Phase II data demonstrating the positive effect of a …
News

Empagliflozin (Jardiance®) receives SMC approval for treatment of heart failure

October 13, 2021 Research and Development

The Scottish Medicines Consortium (SMC) has announced that empagliflozin (Jardiance®) has been accepted for use by NHS Scotland, for the …
News
moderna_norwood_plant

Gavi to purchase 176.5 million doses of Moderna COVID-19 vaccine for low income countries

October 13, 2021 Research and Development

COVAX has purchased more than 210 million doses of their vaccine for delivery to low income countries. This supply agreement …
News
pfizer

Pfizer enlists entire town in Brazil for COVID study

October 7, 2021 Research and Development

An entire town in Brazil has been enrolled by Pfizer to study the transmission of the coronavirus within a vaccinated …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026